• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EphA2 介导的 Shp2 酪氨酸磷酸化在 Shp2 调节的细胞外信号调节激酶激活中的作用。

Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.

机构信息

Department of Cell Biology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.

出版信息

Oncogene. 2013 Nov 7;32(45):5292-301. doi: 10.1038/onc.2012.571. Epub 2013 Jan 14.

DOI:10.1038/onc.2012.571
PMID:23318428
Abstract

Shp2 is a positive regulator for Erk activation downstream of receptor tyrosine kinases for growth factors. It has been controversial how Shp2 induces Erk activation. We here demonstrate that EphA2 is responsible for Shp2-mediated Erk activation by phosphorylating Tyr542 and Tyr580 of Shp2 in the cells stimulated with growth factors. In NMuMG mammary epithelial cells stimulated with hepatocyte growth factor (HGF), HGF-dependent Erk phosphorylation was prolonged only in the presence of EphA2. This Erk activation paralleled the phosphorylation of Tyr542/580 of Shp2 and the association of Grb2 with Shp2, suggesting the positive signal involving Grb2 signal to activate Ras-Erk pathway. Immunohistochemical studies of mammary cancer specimens revealed that the cancer progression was associated with both Tyr580 phosphorylation of Shp2 and increased expression of EphA2, which were also correlated with increased Erk phosphorylation. Overexpression of either Shp2Thr468Met (a phosphatase-defective mutant found in Lentigines, Electrocardiographic abnormalities, Ocular hypertelorism, Pulmonary stenosis, Abnormal genitalia, Retardation of growth and sensorineural Deafness (LEOPARD) syndrome) or Shp2Asn308Asp (a phosphatase-active mutant found in Noonan syndrome) with EphA2 exhibited comparable activation of Erk and stronger activation than wild-type Shp2, suggesting the phosphatase-independent Erk activation. Expression of Shp2Thr468Met with Tyr542/580Phe mutations resulted in the suppression of Erk activation. Phosphatase-active and -inactive, and wild-type Shp2s bound equally to Grb2, suggesting that phosphorylation of Tyr542/580 of Shp2 was essential but not sufficient for Shp2-mediated Erk activation. We found that Gab1 (Grb2-associated binder 1) was involved in the mutant Shp2-mediated Erk activation. Zebrafish injected with Shp2Thr468Met mRNA showed cardiac edema, whereas those depleted of EphA2b showed less phenotype, suggesting that EphA2 might partly account for the phenotype of LEOPARD syndrome. Collectively, tyrosine phosphorylation of Shp2 by EphA2 contributes to the phosphatase-independent Shp2-mediated activation of Erk and might be involved in Shp2-associated diseases.

摘要

Shp2 是生长因子受体酪氨酸激酶下游 Erk 激活的正调节剂。Shp2 如何诱导 Erk 激活一直存在争议。我们在此证明,在受生长因子刺激的细胞中,EphA2 通过磷酸化 Shp2 的 Tyr542 和 Tyr580 负责 Shp2 介导的 Erk 激活。在受肝细胞生长因子 (HGF) 刺激的 NMuMG 乳腺上皮细胞中,只有在 EphA2 存在的情况下,HGF 依赖性 Erk 磷酸化才会延长。这种 Erk 激活与 Shp2 的 Tyr542/580 磷酸化和 Grb2 与 Shp2 的关联平行,表明涉及 Grb2 信号的正信号激活 Ras-Erk 途径。乳腺肿瘤标本的免疫组织化学研究表明,癌症进展与 Shp2 的 Tyr580 磷酸化和 EphA2 的表达增加有关,这也与 Erk 磷酸化的增加有关。EphA2 与 Shp2Thr468Met(在 Lentigines、Electrocardiographic abnormalities、Ocular hypertelorism、Pulmonary stenosis、Abnormal genitalia、Retardation of growth 和 sensorineural Deafness (LEOPARD) 综合征中发现的磷酸酶缺陷突变体)或 Shp2Asn308Asp(在 Noonan 综合征中发现的磷酸酶活性突变体)的过表达均表现出可比的 Erk 激活,并且比野生型 Shp2 更强的激活,表明 Erk 的磷酸酶非依赖性激活。Shp2Thr468Met 与 Tyr542/580Phe 突变体的表达导致 Erk 激活的抑制。磷酸酶活性和非活性以及野生型 Shp2 均与 Grb2 结合相等,表明 Shp2 的 Tyr542/580 磷酸化对于 Shp2 介导的 Erk 激活是必要的,但不是充分的。我们发现 Gab1(Grb2 相关结合物 1)参与了突变 Shp2 介导的 Erk 激活。用 Shp2Thr468Met mRNA 注射的斑马鱼显示出心脏水肿,而 EphA2b 耗尽的斑马鱼则表现出较少的表型,这表明 EphA2 可能部分解释了 LEOPARD 综合征的表型。总之,EphA2 对 Shp2 的酪氨酸磷酸化有助于磷酸酶非依赖性 Shp2 介导的 Erk 激活,并可能参与 Shp2 相关疾病。

相似文献

1
Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.EphA2 介导的 Shp2 酪氨酸磷酸化在 Shp2 调节的细胞外信号调节激酶激活中的作用。
Oncogene. 2013 Nov 7;32(45):5292-301. doi: 10.1038/onc.2012.571. Epub 2013 Jan 14.
2
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.努南综合征相关的SHP2/PTPN11突变体导致表皮生长因子依赖的Gab1结合延长及细胞外信号调节激酶2/丝裂原活化蛋白激酶1持续激活。
Hum Mutat. 2004 Mar;23(3):267-77. doi: 10.1002/humu.20005.
3
Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway.EphA2 的 Y772 磷酸化通过 Shp2/Erk-1/2 信号通路负责 EphA2 依赖性 NPC 鼻咽癌的生长。
Cell Death Dis. 2020 Aug 27;11(8):709. doi: 10.1038/s41419-020-02831-0.
4
Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth.β4整合素激活一条Shp2-Src信号通路,该通路维持肝细胞生长因子诱导的不依赖贴壁的生长。
J Cell Biol. 2006 Dec 18;175(6):993-1003. doi: 10.1083/jcb.200605114. Epub 2006 Dec 11.
5
SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.含SH2结构域的磷酸酶-2蛋白酪氨酸磷酸酶促进FcεRI诱导的Fyn和Erk信号通路激活,从而导致骨髓来源的肥大细胞释放肿瘤坏死因子α。
J Immunol. 2009 Oct 15;183(8):4940-7. doi: 10.4049/jimmunol.0900702. Epub 2009 Sep 28.
6
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.诺南综合征相关 SHP2 突变体通过生长激素诱导的 ERK 过度激活抑制胰岛素样生长因子 1 的释放,这导致了身材矮小。
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4257-62. doi: 10.1073/pnas.1119803109. Epub 2012 Feb 27.
7
The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.多站点对接蛋白 Grb2 相关结合蛋白 1(Gab1)以 SHP2、Grb2 和时间依赖的方式增强白细胞介素 6 诱导的 MAPK 通路激活。
Cell Commun Signal. 2019 Oct 24;17(1):135. doi: 10.1186/s12964-019-0451-2.
8
Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.信号衔接蛋白ShcD抑制Ret和Trk神经营养因子受体远端的细胞外信号调节激酶(Erk)磷酸化。
J Biol Chem. 2017 Apr 7;292(14):5748-5759. doi: 10.1074/jbc.M116.770511. Epub 2017 Feb 17.
9
Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects.Shp2基因敲低以及努南/豹皮综合征突变型Shp2诱导的原肠胚形成缺陷。
PLoS Genet. 2007 Dec;3(12):e225. doi: 10.1371/journal.pgen.0030225.
10
Oncogenic Shp2 disturbs microtubule regulation to cause HDAC6-dependent ERK hyperactivation.致癌 Shp2 扰乱微管调节导致 HDAC6 依赖性 ERK 过度激活。
Oncogene. 2014 May 29;33(22):2938-46. doi: 10.1038/onc.2013.241. Epub 2013 Jun 17.

引用本文的文献

1
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases.将靶向Shp2作为神经退行性疾病的治疗策略。
Transl Psychiatry. 2025 Jan 10;15(1):6. doi: 10.1038/s41398-024-03222-1.
2
Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies.Ephrin和Eph家族在心血管发育及病变方面的最新进展。
iScience. 2024 Jul 19;27(8):110556. doi: 10.1016/j.isci.2024.110556. eCollection 2024 Aug 16.
3
Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer.
羽扇豆醇与5-氟尿嘧啶协同作用,以对抗三阴性乳腺癌中c-MET/EphA2介导的化疗耐药性。
iScience. 2023 Nov 4;26(12):108395. doi: 10.1016/j.isci.2023.108395. eCollection 2023 Dec 15.
4
Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes.用活性位点抑制剂靶向SHP2可阻断信号传导和乳腺癌细胞表型。
ACS Bio Med Chem Au. 2023 Jul 14;3(5):418-428. doi: 10.1021/acsbiomedchemau.3c00024. eCollection 2023 Oct 18.
5
A comprehensive review of SHP2 and its role in cancer.SHP2 及其在癌症中的作用的全面综述。
Cell Oncol (Dordr). 2022 Oct;45(5):729-753. doi: 10.1007/s13402-022-00698-1. Epub 2022 Sep 6.
6
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.靶向蛋白磷酸酶治疗炎症相关疾病:从信号转导到治疗。
Signal Transduct Target Ther. 2022 Jun 4;7(1):177. doi: 10.1038/s41392-022-01038-3.
7
PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease.PTPN11 基因突变及其与先天性心脏病风险的关联。
Dis Markers. 2022 Apr 9;2022:8290779. doi: 10.1155/2022/8290779. eCollection 2022.
8
Strategies to overcome drug resistance using SHP2 inhibitors.使用SHP2抑制剂克服耐药性的策略。
Acta Pharm Sin B. 2021 Dec;11(12):3908-3924. doi: 10.1016/j.apsb.2021.03.037. Epub 2021 Mar 28.
9
The tyrosine phosphatase SHP-2 dephosphorylated by ALV-J via its Env efficiently promotes ALV-J replication.禽白血病病毒 J 型通过其包膜蛋白使酪氨酸磷酸酶 SHP-2 去磷酸化,从而有效地促进了禽白血病病毒 J 型的复制。
Virulence. 2021 Dec;12(1):1721-1731. doi: 10.1080/21505594.2021.1939952.
10
Helicobacter Pylori Variants with ABC-Type Tyrosine Phosphorylation Motif in Gastric Biopsies of Ghanaian Patients.加纳患者胃活检中具有 ABC 型酪氨酸磷酸化基序的幽门螺杆菌变体。
Biomed Res Int. 2021 Mar 30;2021:6616059. doi: 10.1155/2021/6616059. eCollection 2021.